Dr. Koos Stiekema was was sued by the pharmaceutical company Organon for violating his confidentiality agreement after discussing his concerns with three ethics committees that the lowest dose of the drug pentasaccharide being tested in patients with acute coronary syndrome would not be sufficient to prevent myocardial infarctions.
Dr. Koos Stiekema was was sued by the pharmaceutical company Organon for. Dr. Koos Stiekema were violating his confidentiality agreement after. The lowest dose of the drug pentasaccharide would not be sufficient to prevent myocardial infarctions. This was what Dr. Koos Stiekema were discussing his concerns with three ethics committees. This drug pentasaccharide is being tested in patients with acute coronary syndrome.